You are here

luveltamab tazevibulin

Sutro shells out latest update on ovarian cancer treatment, plans for pivotal trial

Endpoints

Tue, 01/10/23 - 10:54 am

Sutro BioPharma

clinical trials

antibody-drug conjugate

luveltamab tazevibulin